|
[1] Liver Failure and Artificial Liver Group,Chinese Society of Infectious Diseases,CMA;Severe Liver Disease and Artificial Liver Group,Chinese Sociely of Hepatology,CMA.Guideline for diagnosis and treatment of liver failure(2012 version)[J].Chin J Clin Infect Dis,2012,5(6):321-327.(in Chinese)中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2012年版)[J].中华临床感染病杂志,2012,5(6):321-327.
|
|
[2] POISON J,LEE WM,American Association for the Study of Liver Disease.AASLD position paper:the management of acute liver failure[J].Hepatology,2005,41(5):1179-1197.
|
|
[3]WILLIAM M,LEE AM,LARSON R,et al.AASLD position paper:the management of acute liver failure:update 2011[J].National Guideline Clearinghouse,2012,65(4):1433-1441.
|
|
[4]SARIN SK,KUMAR A,ALMEIDA JA,et al.Acute-on-chronic liver failure:consensus recommendations of the Asian Pacific Association for the study of the liver(APASL)[J].Hepatol Int,2009,3(1):269-282.
|
|
[5]SARIN SK,KEDARISETTY CK,ABBAS Z,et al.Acute-on-chronic liver failure:consensus recommendations of the Asian Pacific Association for the Study of the Liver(APASL)2014[J].Hepatol Int,2014,8(4):453-471.
|
|
[6]Liver Failure and Artificial Liver Group,Chinese Society of Infectious Diseases,Chinese Medical Association;Severe Liver Diseases and Artificial Liver Group,Chinese Society of Hepatology,Chinese Medical Association.Diagnostic and treatment guidelines for liver failure[J].Chin J Hepatol,2006,14(9):643-646.(in Chinese)中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646.
|
|
[7]ZHANG Q,LI Y,HAN T,et al.Comparison of current diagnostic criteria for acute-on-chronic liver failure[J].PLo S One,2015,10(3):e122158.
|
|
[8]SHI Y,YANG Y,HU Y,et al.Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extra hepatic insults[J].Hepatology,2015,62(1):232-242.
|
|
[9]GUSTOT T,FERNANDEZ J,GARCIA E,et al.Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis[J].Hepatology,2015,62(1):243-252.
|
|
[10]CORDOBA J,VENTURA-COTS M,SIMN-TALERO M,et al.Characteristics risk factors and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure(ACLF)[J].J Hepatol,2014,60(2):275-281.
|
|
[11]LI H,XIA Q,ZENG B,et al.Sub-massive hepatic necrosis distinguishes HBV associated acute-on-chronic liver failure from cirrhotic patients with acute decompensation[J].J Hepatol,2015,63(1):50-59.
|
|
[12]KAMATH PS,WIESNER RH,MALINCHOC M,et al.A model to predict survival in patients with end-stage liver disease[J].Hepatology,2001,33(2):464-470.
|
|
[13]WU CH,TIAN GS,XU XY,et al.Assessment of prognosis and curative effect in patients with chronic severe hepatitis using the model for end stage liver disease scores[J].Chin Med J,2006,19(2):148-150.
|
|
[14]SUN QF,DING JG,XU DZ,et al.Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model[J].J Viral Hepat,2009,16(7):464-470.
|
|
[15]ASRANI SK,KIM WR.Model for end stage liver disease:end of the first decade[J].Clin Liver Dis,2011,15(1):685-698.
|
|
[16]O'GRADY JG,ALEXANDER GJ,HAYLLAR KM,et al.Early indicators of prognosis in fulminant hepatic failure[J].Gastroenterology,1989,97(2):439-445.
|
|
[17]GOTTHARDT D,RIEDIGER C,WEISS KH,et al.Fulminant hepatic failure:etiology and indications for liver transplantation[J].Nephrol Dial Transplant,2007,22(Suppl 8):viii5-viii8.
|
|
[18]CHOLONGITAS E,THEOCHARIDOU E,VASIANOPOULOU P,et al.Comparison of the sequential organ failure assessment score with the King's College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure[J].Liver Transpl,2012,18(4):405-412.
|
|
[19]Mc PHAIL MJ,WENDON JA,BENAL W.Meta-analysis of performance of King's College Hospital Criteria in prediction of outcome in nonparacetamol-induced acute liver failure[J].J Hepatol,2010,53(3):492-499.
|
|
[20]PARKASH O,MUMTAZ K,HAMID S,et al.MELD score:utility and comparison with King's College criteria in non-acetaminophen acute liver failure[J].J Coil Physicians Surg Pak,2012,22(8):492-496.
|
|
[21]ZHANG L,HAO CQ,LIU JF,et al.Meta-analysis of the shortterm effects of lamivudine treatment for severe chronic hepatitis B[J].Virol J,2013,10(1):134-138.
|
|
[22]Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B:a 2015 update[J].J Clin Hepatol,2015,31(12):1941-1960.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年更新版)[J].临床肝胆病杂志,2015,31(12):1941-1960.
|
|
[23]LIAW YF,SHEEN IS,LEE CM,et al.Tenofovir disoproxil fumarate(TDF),emtricitabine/TDF,and entecavir in patients with decompensated chronic hepatitis B liver disease[J].Hepatology,2011,53(1):62-72.
|
|
[24]SU HB,WANG HF.Antiviral therapy for hepatitis B liver failure[J].J Clin Hepatol,2012,28(10):726-728.(in Chinese)苏海滨,王慧芬.乙型肝炎肝衰竭的抗病毒治疗[J].临床肝胆病杂志,2012,28(10):726-728.
|
|
[25]TANG WL,XIE Q.Advance in antiviral treatment of hepatitis B related liver failure[J].Chin J Hepatol,2012,20(6):408-410.(in Chinese)汤伟亮,谢青.乙型肝炎相关肝衰竭抗病毒治疗研究进展[J].中华肝脏病杂志,2012,20(6):408-410.
|
|
[26]KHAN AA,PARVEEN N,MAHABOOB VS,et al.Safety and efficacy of autologous bone marrow stem cell transplantation through hepatic artery for the treatment of chronic liver failure:a preliminary study[J].Transplant Proc,2008,40(4):1140-1144.
|
|
[27]PENG L,XIE DY,LIN BL,et al.Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B:short-term and long-term outcomes[J].Hepatology,2011,54(5):1891-1892.
|
|
[28]LI J,ZHANG L,XIN J,et al.Immediate intraportal transplantation of human bone marrow mesenchymal stem cells prevents death from fulminant hepatic failure in pigs[J].Hepatology,2012,56(3):1044-1052.
|
DownLoad: